2024-12-23 09:20:49
Live from ASCO 2023 | For the Third Consecutive Year, Ascentage Pharma Releases Promising Results of Alrizomadlin plus Pembrolizumab in Patients with Cutaneous Melanoma that Failed Immuno-Oncologic (IO) Therapies
Corporate/ 2023-07-24
Live from ASCO 2023 | For the Third Cons...

SUZHOU,China,and ROCKVILLE,Md.,June 5,2023-- Ascentage Pharma (6855.HK),a global biopharmaceutical company engaged in developing novel thera...

Impact Therapeutics Entered into Global Partnership with Eikon Therapeutics to Develop and Commercialize PARP1 Selective Inhibitors
Health/ 2023-07-22
Impact Therapeutics Entered into Global ...

SHANGHAI and HAYWARD,Calif.,June 1,2023--IMPACT Therapeutics ("Impact"),a biopharmaceutical company focusing on the discovery and ...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release